These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 12642053)

  • 1. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.
    Hakin-Smith V; Jellinek DA; Levy D; Carroll T; Teo M; Timperley WR; McKay MJ; Reddel RR; Royds JA
    Lancet; 2003 Mar; 361(9360):836-8. PubMed ID: 12642053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers and long-term survivors of glioblastoma multiforme.
    McKay MJ; MacCallum P; Reddel RR; Royds J
    Cancer J; 2004; 10(5):333. PubMed ID: 15530263
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.
    Chen YJ; Hakin-Smith V; Teo M; Xinarianos GE; Jellinek DA; Carroll T; McDowell D; MacFarlane MR; Boet R; Baguley BC; Braithwaite AW; Reddel RR; Royds JA
    Cancer Res; 2006 Jul; 66(13):6473-6. PubMed ID: 16818615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival.
    McDonald KL; McDonnell J; Muntoni A; Henson JD; Hegi ME; von Deimling A; Wheeler HR; Cook RJ; Biggs MT; Little NS; Robinson BG; Reddel RR; Royds JA
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):729-36. PubMed ID: 20535033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival.
    Royds JA; Al Nadaf S; Wiles AK; Chen YJ; Ahn A; Shaw A; Bowie S; Lam F; Baguley BC; Braithwaite AW; MacFarlane MR; Hung NA; Slatter TL
    PLoS One; 2011; 6(10):e26737. PubMed ID: 22046342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential clinical role of telomere length in human glioblastoma.
    La Torre D; Aguennouz M; Conti A; Giusa M; Raffa G; Abbritti RV; Germano' A; Angileri FF
    Transl Med UniSa; 2011 Sep; 1():243-70. PubMed ID: 23905037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT).
    Jeitany M; Pineda JR; Liu Q; Porreca RM; Hoffschir F; Desmaze C; Silvestre DC; Mailliet P; Junier MP; Londoño-Vallejo A; Ségal-Bendirdjian E; Chneiweiss H; Boussin FD
    Int J Cancer; 2015 Apr; 136(7):1546-58. PubMed ID: 25175359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
    Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
    Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
    Grobelny JV; Kulp-McEliece M; Broccoli D
    Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
    Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
    Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma.
    Hung NA; Eiholzer RA; Kirs S; Zhou J; Ward-Hartstonge K; Wiles AK; Frampton CM; Taha A; Royds JA; Slatter TL
    Mod Pathol; 2016 Mar; 29(3):212-26. PubMed ID: 26769142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas.
    Morii K; Tanaka R; Onda K; Tsumanuma I; Yoshimura J
    Biochem Biophys Res Commun; 1997 Oct; 239(3):830-4. PubMed ID: 9367854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
    Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
    J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.
    Miracco C; De Santi MM; Luzi P; Lalinga AV; Laurini L; De Nisi MC; Angeloni G; Brogi M; Cardone C; Carducci A; Arcuri F; Tosi P; Rubino G; Pirtoli L
    Int J Oncol; 2003 Dec; 23(6):1529-35. PubMed ID: 14612923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
    Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
    J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
    Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
    Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
    Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
    Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma.
    Lee YK; Park NH; Lee H
    Int J Gynecol Cancer; 2012 Mar; 22(3):434-41. PubMed ID: 22266933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.